iTeos Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
29 Aug 2025	Form 4: Call Matthew, Chief Operating Officer Disposed of 161,898 shares (Tender Offer) · Disposed of 416,773 Stock Option (Right to Buy) (Disposition to Issuer)
29 Aug 2025	Form 4: Detheux Michel, Director Disposed of 247,930 shares (Tender Offer) · Disposed of 858,708 Stock Option (Right to Buy) (Disposition to Issuer)
29 Aug 2025	Form 4: Lee David K, Director Disposed of 44,766 Stock Option (Right to Buy) (Disposition to Issuer)
29 Aug 2025	Form 4: Feltquate David, Chief Medical Officer Disposed of 47,000 shares (Tender Offer)
29 Aug 2025	Form 4: Gall Matthew, Chief Financial Officer Disposed of 89,429 shares (Tender Offer) · Disposed of 447,646 Stock Option (Right to Buy) (Disposition to Issuer)
29 Aug 2025	Form 4: McGrath Yvonne, Chief Scientific Officer Disposed of 46,300 shares (Tender Offer) · Disposed of 176,123 Stock Option (Right to Buy) (Disposition to Issuer)
29 Aug 2025	Form 4: Rhoads Ann D, Director Disposed of 27,178 Stock Option (Right to Buy) (Disposition to Issuer)
29 Aug 2025	Form 4: Hallal David, Director Disposed of 171,300 Stock Option (Right to Buy) (Disposition to Issuer)
11 Jun 2025	Form 4: Detheux Michel, Chief Executive Officer Received 52,282 shares by exercise or conversion ($225K) · Sold 52,282 shares ($524K) · Received 164,310 shares by exercise or conversion ($707K) · 1 more
06 Jun 2025	Form 4: Detheux Michel, Chief Executive Officer Received 52,283 shares by exercise or conversion ($225K) · Sold 52,283 shares ($528K) · Received 52,282 shares by exercise or conversion ($225K) · 3 more
06 Jun 2025	Form 4: Hallal David, Director Received 38,227 shares by exercise or conversion ($164K) · Sold 38,227 shares ($385K) · Received 38,227 shares by exercise or conversion ($164K) · 3 more
16 May 2025	Form 4: EcoR1 Capital, Llc, 10% owner Bought 1,658,978 shares ($12.3M) · Bought 3,300,000 shares ($26.4M)
15 May 2025	Form 4: Gadicke Ansbert, Former 10% Owner and 3 others Sold 1,031,931 shares ($8.32M)
15 May 2025	Form 4: Mpm Bioventures 2018, L.p., Former 10% Owner and 2 others Sold 630,191 shares ($5.08M)
15 May 2025	Form 4: Mpm BioVentures 2014, L.p., Former 10% Owner and 8 others Sold 630,191 shares ($5.08M)
14 May 2025	Form 4: Van Hauwermeiren Timothy, Director Received 22,346 shares by exercise or conversion ($96.1K)
11 Mar 2025	Form 4: Detheux Michel, Chief Executive Officer Received 77,000 shares as a grant or award · Granted 459,000 Stock Option (Right to Buy)
11 Mar 2025	Form 4: Gall Matthew, Chief Financial Officer Received 24,000 shares as a grant or award · Granted 145,000 Stock Option (Right to Buy)
11 Mar 2025	Form 4: McGrath Yvonne, Chief Scientific Officer Received 15,300 shares as a grant or award · Granted 91,000 Stock Option (Right to Buy)
11 Mar 2025	Form 4: Call Matthew, Chief Operating Officer Received 24,000 shares as a grant or award · Granted 145,000 Stock Option (Right to Buy)

Comments